Outer Biosciences Trains AI on Living Skin For Cosmetics, Not Drugs
Four years in stealth, $23m raised, and a closed loop between a model and donated human tissue — aimed at a market with no approval gate at the end of it.
Aug 22, 2026

Four years in stealth, $23m raised, and a closed loop between a model and donated human tissue — aimed at a market with no approval gate at the end of it.
Aug 22, 2026

354 confirmed binders from 1,320 designs, up to 12,500 H100-hours a session — and the capability is blocked in Anthropic's most capable model.
Aug 19, 2026

Bunsen plans, executes and interprets molecular discovery cycles across the company's physics-based tools. What it does not come with is any evidence that it works.
Jul 28, 2026

The pharma giant says it will run proprietary AI models across oncology, immunology and neuroscience on what it calls the most powerful single-owned Nvidia system in life sciences — up to 10x the performance per megawatt of its predecessor.
Jul 20, 2026

Google's AI lab is standing up pathogen surveillance, faster vaccine design and a rapid-response drug-discovery unit — explicitly covering both natural outbreaks and AI-enabled misuse.
Jul 17, 2026

In beta since June 30 for paid subscribers, it plugs Claude into 60-plus scientific skills and databases with reproducible, reviewer-checked outputs — plus up to 50 grants of $30,000 to seed real research.
Jul 7, 2026
